118288-08-7
Chemical Structure
Lafutidine
Synonym(s): FRG-8813
- CAS No.: 118288-08-7
- Formula:C22H29N3O4S
- Molecular Weight:431.55
IUPAC Name: (Z)-2-((furan-2-ylmethyl)sulfinyl)-N-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide
InChIKey: KMZQAVXSMUKBPD-DJWKRKHSSA-N
SMILES: O=C(NC/C=C\COC1=NC=CC(CN2CCCCC2)=C1)CS(CC3=CC=CO3)=O
Biological Activity: Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lafutidine | 99.56% | Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lafutidine (Standard) | ≥98% | Lafutidine (Standard) is the analytical standard of Lafutidine. This product is intended for research and analytical applications. Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lafutidine-d10 | Lafutidine-d10 is deuterium labeled Lafutidine. Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||